SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.61 CNY | -0.66% |
|
+1.14% | +8.38% |
| Apr. 16 | Shyndec Pharmaceutical's Unit Gets Nod to Market Empagliflozin Tablets | MT |
| Apr. 15 | China stocks rise after new guidelines; HK shares drop | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. is a China-based company principally engaged in the research and development, production and sales of pharmaceutical products. The Company's main products are antibiotics, circulatory system drugs and biological products, including garlic oil soft capsules, lecithin soft capsules and deep-sea fish oil soft capsules. Its bulk pharmaceutical chemicals (BPCs) include macrolide antibiotics, antiviral, anti-tumor, cardiovascular, hormones and weight loss drugs. The Company also offers topical preparations, such as gynecological suppositories and dermatology preparations.
Sector
Pharmaceuticals
Calendar
2024-04-29
- Q1 2024 Earnings Release
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
10.61
Average target price
-
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +8.38% | 1.96B | |
| +5.31% | 70.44B | |
| +10.97% | 8.94B | |
| -16.83% | 4.75B | |
| +43.48% | 4.5B | |
| +3.20% | 3.85B | |
| +18.82% | 2.38B | |
| -21.36% | 2.34B | |
| -29.67% | 2.2B | |
| +3.90% | 1.65B |
- Stock Market
- Equities
- 600420 Stock
- News Shanghai Shyndec Pharmaceutical Co., Ltd.
- Shyndec Pharmaceutical Unit's Cefprozil Tablets Passes Regulatory Evaluation
